《肾意义单克隆丙种球蛋白病及B细胞恶性肿瘤中与单克隆免疫球蛋白相关的肾损害：实际临床实践》勘误[第9卷，第4期，增刊，2024年4月，第S624 - S625页]
Corrigendum to "WCN24-1897 MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE AND MONOCLONAL IMMUNOGLOBULIN RELATED KIDNEY DAMAGE IN B-CELL MALIGNANCIES: THE REAL CLINICAL PRACTICE" [ Volume 9, Issue 4, Supplement, April 2024, Page S624-S625].
作者信息
Zakharova Elena, Zykova Anastasia, Stolyarevich Ekaterina, Vorobyeva Olga
机构信息
Moscow, Nephrology, Russia.
Nephrology, Botkin Hospital, Moscow.
出版信息
Kidney Int Rep. 2024 Apr 29;9(7):2310. doi: 10.1016/j.ekir.2024.04.051. eCollection 2024 Jul.
Abstract
[This corrects the article DOI: 10.1016/j.ekir.2024.02.1314.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.ekir.2024.02.1314。]
相似文献
1
Corrigendum to "WCN24-1897 MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE AND MONOCLONAL IMMUNOGLOBULIN RELATED KIDNEY DAMAGE IN B-CELL MALIGNANCIES: THE REAL CLINICAL PRACTICE" [ Volume 9, Issue 4, Supplement, April 2024, Page S624-S625].《肾意义单克隆丙种球蛋白病及B细胞恶性肿瘤中与单克隆免疫球蛋白相关的肾损害：实际临床实践》勘误[第9卷，第4期，增刊，2024年4月，第S624 - S625页]
Kidney Int Rep. 2024 Apr 29;9(7):2310. doi: 10.1016/j.ekir.2024.04.051. eCollection 2024 Jul.
2
Corrigendum to "WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS" [ Volume 9, Issue 4, Supplement, April 2024, Page S541].《“WCN24 - 2499 小窝蛋白 - 1 和小窝蛋白 - 2 作为大鼠急性胆汁淤积性肾损伤潜在尿液早期生物标志物”的勘误》[第9卷，第4期，增刊，2024年4月，第S541页]
Kidney Int Rep. 2024 Jun 8;9(8):2583-2584. doi: 10.1016/j.ekir.2024.06.012. eCollection 2024 Aug.
3
Corrigendum to "WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE" [ Volume 9, Issue 4, Supplement, April 2024, Page S86].《慢性肾脏病患者肾活检的临床特征、诊断、治疗干预及并发症——单中心20年经验》勘误[第9卷，第4期，增刊，2024年4月，第S86页]
Kidney Int Rep. 2024 May 23;9(7):2312-2313. doi: 10.1016/j.ekir.2024.05.019. eCollection 2024 Jul.
4
Corrigendum to "WCN24-2021 KNOWLEDGE ATTITUDES AND BELIEFS ABOUT KIDNEY TRANSPLANTATION IN JAMAICAN RESIDENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S482].《牙买加居民对肾移植的知识、态度和信念》勘误 [第9卷，第4期，增刊，2024年4月，第S482页]
Kidney Int Rep. 2024 Jun 8;9(8):2582-2583. doi: 10.1016/j.ekir.2024.06.011. eCollection 2024 Aug.
5
Corrigendum to "WCN24-1675 ACUTE NECROTIZING ULCERATIVE GENGIVITIS IN KIDNEY TRANSPLANTATION: A CASE REPORT" [ Volume 9, Issue 4, Supplement, April 2024, Page S473].《肾移植中的急性坏死性溃疡性龈炎：一例报告》勘误 [第9卷，第4期，增刊，2024年4月，第S473页]
Kidney Int Rep. 2024 Apr 19;9(6):1937-1938. doi: 10.1016/j.ekir.2024.04.037. eCollection 2024 Jun.
6
Corrigendum to "WCN24-2216 Clinical-surgical parameters in patients with arteriovenous fistulas failure in SERMESA'S nephrological centers during 2022" [ Volume 9, Issue 4, Supplement, April 2024, Page S411].《“2022年SERMESA肾脏病中心动静脉内瘘失败患者的临床手术参数”勘误》[第9卷，第4期，增刊，2024年4月，第S411页]
Kidney Int Rep. 2024 Apr 18;9(6):1940-1942. doi: 10.1016/j.ekir.2024.04.035. eCollection 2024 Jun.
7
Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [ Volume 9, Issue 4, Supplement, April 2024, Page S339].《“WCN24 - 1105 尼日利亚成年 HIV 感染者中替诺福韦诱导的肾小管功能障碍的药物遗传学风险因素”勘误》[第 9 卷，第 4 期，增刊，2024 年 4 月，第 S339 页]
Kidney Int Rep. 2024 May 17;9(7):2313-2314. doi: 10.1016/j.ekir.2024.05.018. eCollection 2024 Jul.
8
Corrigendum to "WCN24-843 ULTRAPROCESSED FOODS: DETERMINANTS AND RELATIONSHIP WITH BIOCHEMICAL PARAMETERS IN CHRONIC HEMODIALYSIS PATIENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S371].《“WCN24 - 843 超加工食品：慢性血液透析患者的决定因素及其与生化参数的关系”勘误》[第9卷，第4期，增刊，2024年4月，第S371页]
Kidney Int Rep. 2024 Apr 18;9(6):1939. doi: 10.1016/j.ekir.2024.04.036. eCollection 2024 Jun.
9
Corrigendum to "WCN24-1065 QUALITY INDICATORS IN PERITONEAL DIALYSIS IN A CLINIC FROM FLORIANÓPOLIS, SANTA CATARINA, BRAZIL" [ Volume 9, Issue 4, Supplement, April 2024, Page S586].对《巴西圣卡塔琳娜州弗洛里亚诺波利斯一家诊所腹膜透析的质量指标》的勘误[第9卷，第4期，增刊，2024年4月，第S586页]
Kidney Int Rep. 2024 Apr 18;9(6):1943. doi: 10.1016/j.ekir.2024.04.033. eCollection 2024 Jun.
10
Corrigendum to "WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS" [ Volume 9, Issue 4, Supplement, April 2024, Page S637].《WCN24 - 1267 恩格列净改善内皮细胞活力并保护其免受晚期糖基化终末产物影响》勘误 [第9卷，第4期，增刊，2024年4月，第S637页]
Kidney Int Rep. 2024 Apr 29;9(7):2311. doi: 10.1016/j.ekir.2024.04.052. eCollection 2024 Jul.
Zotero 插件